Skip to main content
Fig. 3 | BMC Veterinary Research

Fig. 3

From: Oral chondroitin sulfate and prebiotics for the treatment of canine Inflammatory Bowel Disease: a randomized, controlled clinical trial

Fig. 3

Concentrations of serum cholesterol (a), PON1 (b) and TAC (c) in groups A (placebo) and B (supplement) at the initial visit (1; 15 days before treatment start), and at 30 (2), 60 (3), 90 (4), 120 (5) and 180 (6) days of treatment. Asterisks indicate statistical significance compared to pretreatment values within each group (one-way ANOVA; *p < 0.05; **p < 0.01). Differences between groups are also represented (unpaired t-test; ϕp < 0.05; ϕϕp < 0.01)

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us